Navigation Links
Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome
Date:8/3/2009

PALO ALTO, Calif., Aug. 3 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK) today announced that the positive results from a Phase 1 multicenter, dose escalation study of ezatiostat hydrochloride (TELINTRA, TLK199) tablets in patients with Myelodysplastic Syndrome (MDS) have been published in a leading peer reviewed journal, Blood, 25 June 2009; Vol. 113, No. 26, pp. 6533-6540. Positive results from a separate Phase 1-2a study in MDS patients involving an intravenous formulation of TELINTRA were published earlier in the Journal of Hematology and Oncology,13 May 2009; Vol. 2, No.20, pp. 20-32. The findings reported from these studies support the further development of TELINTRA. Phase 2 studies are ongoing in MDS (enrollment completion expected by year end), and Severe Chronic Idiopathic Neutropenia. Reprints of both publications are available from Telik.

Background on MDS and TELINTRA

MDS is a heterogeneous group of blood stem cell disorders of increasing incidence. MDS is characterized by ineffective blood cell production involving one or more of the red cell, white cell or platelet lineages and with MDS patients having a variable risk of progression to leukemia. There remains a need for effective, well tolerated therapies for MDS having novel mechanisms of action. TELINTRA has a novel mechanism of action that inhibits a target enzyme called glutathione S- transferase P1-1 which in turn facilitates the activation of JNK kinase, a key regulator of cellular growth and differentiation of blood. TELINTRA has been shown to stimulate normal multilineage differentiation of blood stem cell precursors and induce cancer cell death in human leukemia cell lines. Additional information on TELINTRA is available at www.telik.com.'/>"/>

SOURCE Telik, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Telik Announces Presentation at ASCO Annual Meeting
2. Teliks Proteasome Inhibitor Program Meets a Preclinical Development Milestone
3. Telik Announces Initiation of Two Phase 2 Randomized TELINTRA Studies
4. Telik Announces Telintra Presentation at American Society of Hematology Annual Meeting
5. Telik Announces Preclinical Data Demonstrating Anti-Cancer Activity of Dual Inhibitors of Aurora Kinase and VEGFR2
6. Telik Announces Presentation of Preclinical Data on Dual Inhibitors of Aurora Kinases and VEGFR2
7. Cryo-Cell Announces Celle(SM) Research and Development Collaboration with Cryopraxis Cryobiology Ltd.
8. NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
9. Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma
10. Cardica Announces Publication of Pivotal PAS-Port(R) Proximal Anastomosis System Clinical Trial Results
11. Poniard Pharmaceuticals Announces Positive Cardiac Safety Data From Picoplatin Phase 1 Trial Supporting NDA Filing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... , May 6, 2015 Eli Lilly and ... establish a new drug delivery and device innovation center ... strategic location that will help attract top scientists and ... presence. The Lilly Cambridge Innovation Center, ... life science experts and organizations to explore how emerging ...
(Date:5/6/2015)... May 6, 2015  IGI Laboratories, Inc. (NYSE-MKT: IG), a ... company, will be presenting today at the Deutsche Bank 40th ... May 6 th and 7 th at The ... Jason Grenfell-Gardner , CEO and President and Jenniffer ... present today, May 6, 2015, at 3:30 p.m. ET.   ...
(Date:5/6/2015)... , May 6, 2015 Neuralstem, Inc. (NYSE ... technology to develop small molecule and cell therapy treatments ... Jonathan Lloyd Jones to the position of ... Mr. Lloyd Jones brings to ... and business development experience.   Most recently, Mr. Lloyd ...
Breaking Medicine Technology:Eli Lilly and Company Reveals Plan for Innovation Center in Cambridge, Massachusetts 2Eli Lilly and Company Reveals Plan for Innovation Center in Cambridge, Massachusetts 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 2Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 4
... MIAMI, April 6, 2011 Fuisz Pharma LLC announced ... that facilitate swallowing and esophageal transit. ... thereof speed esophageal transit by 80%, ease the swallowing ... as compared with the conventional tablet designs currently used. ...
... ANDOVER, Mass., April 6, 2011 Smith & Nephew,s ... today announced that its TRUCLEAR™ System, an operative hysteroscopy ... has surpassed the 30,000 procedure milestone. The ... the visualization capabilities of a hysteroscope with minimally invasive ...
Cached Medicine Technology:Fuisz Pharma LLC Develops a New Generation of Oral Solid Dosage Form Shapes That Facilitate Swallowing and Esophageal Transit 2Smith & Nephew's TRUCLEAR System: A Gold Standard for Removal of Intrauterine Polyps and Fibroids 2Smith & Nephew's TRUCLEAR System: A Gold Standard for Removal of Intrauterine Polyps and Fibroids 3Smith & Nephew's TRUCLEAR System: A Gold Standard for Removal of Intrauterine Polyps and Fibroids 4
(Date:5/6/2015)... Los Angeles (PRWEB) May 06, 2015 ... WaterAid, the #1 ranked international water, sanitation and hygiene ... work for communities across the world and it brings ... Lindsey Carnett, CEO of Marketing Maven. “The ongoing relationship ... the opportunities available for people to learn about and ...
(Date:5/6/2015)... 06, 2015 Wolters Kluwer , ... and students, announced today that in a survey of ... use of the clinical decision support resource improves the ... of 2014, UpToDate users in more than 170 countries ... month, on average. In Germany alone, 95% of all ...
(Date:5/6/2015)... has opened press registration for TU-Automotive Detroit as the ... headlines of major publications world-wide. With 150+ speakers from ... to share their visions for the future of connected ... to go behind the scenes and hear major automakers’ ... year we’re releasing a preview of all the major ...
(Date:5/6/2015)... 06, 2015 Water NSW ... technology to manage and distribute imagery, LiDAR, and Elevation ... of the driest continents on earth, and the need ... drought and erratic seasonal rainfalls has driven the development ... Water NSW manages raw water supplies for NSW, including ...
(Date:5/6/2015)... Cloud security companies Sookasa Inc . ... to help small-to-medium businesses secure their sensitive data more ... teaming up to transition SafeMonk customers to Sookasa’s feature-rich ... welcome SafeMonk users to the Sookasa family, and it’s ... the global powerhouse SafeNet (now Gemalto IDSS), are giving ...
Breaking Medicine News(10 mins):Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 3Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 2Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 3Health News:Press Registration for TU-Automotive Detroit Now Open 2Health News:Water NSW Unlocks Imagery and Elevation Data Archive Across the Enterprise using Hexagon Geospatial Solutions 2Health News:Water NSW Unlocks Imagery and Elevation Data Archive Across the Enterprise using Hexagon Geospatial Solutions 3Health News:Sookasa Grows Globally With SafeMonk Partnership 2Health News:Sookasa Grows Globally With SafeMonk Partnership 3
... the place of amputation for bone and soft tissue sarcomas ... much or even any additional benefit to patients according to ... 2009 issue of Cancer , a peer-reviewed journal of ... rethink the pros and cons of limb-sparing surgery and amputation. ...
... , , , ... An estimated 200,000 Americans will die needlessly from preventable ... a wide-ranging Hearst national investigation, which began reporting the findings today [ ... ago that laid out the scope of the problem and urged the ...
... helpful tips , SATURDAY, Aug. 8 (HealthDay News) -- To ... if parents and children are well-prepared, advises the American Society ... of stress for a person of any age, but when ... sensitivity is added," ASA President Dr. Roger A. Moore said ...
... , OAKLAND, Calif., Aug. 7 Kaiser Foundation Health ... a combined total operating revenue of $10.5 billion for the quarter ... quarter of last year. Operating income in the second quarter ... last year. Net non-operating income was $209 million in the ...
... , , WASHINGTON, Aug. ... Jorge Luis Pacheco, 50, were each sentenced to 97 months ... sentenced to 63 months in prison, for their roles in ... unnecessary HIV infusion treatments, Assistant Attorney General Lanny A. Breuer ...
... , NEW YORK, Aug. 7 Duane ... Reade Inc. and Duane Reade (collectively, the "Issuers"), had closed ... Secured Notes due August 1, 2015 (the "Notes"). The ... The Notes were priced at 97.417%, representing a yield to ...
Cached Medicine News:Health News:Limb-sparing surgery may not provide better quality of life than amputation for bone cancer patients 2Health News:Hearst National Investigation Finds Americans Are Continuing to Die in Staggering Numbers From Preventable Medical Injuries 2Health News:Hearst National Investigation Finds Americans Are Continuing to Die in Staggering Numbers From Preventable Medical Injuries 3Health News:Hearst National Investigation Finds Americans Are Continuing to Die in Staggering Numbers From Preventable Medical Injuries 4Health News:Hearst National Investigation Finds Americans Are Continuing to Die in Staggering Numbers From Preventable Medical Injuries 5Health News:Good Planning Paves Way for Kid's Operation 2Health News:Kaiser Foundation Health Plan and Hospitals Report Second Quarter 2009 Financial Results 2Health News:Kaiser Foundation Health Plan and Hospitals Report Second Quarter 2009 Financial Results 3Health News:Kaiser Foundation Health Plan and Hospitals Report Second Quarter 2009 Financial Results 4Health News:Federal Judge Sentences Defendants Who Perpetrated $10.9 Million Medicare Fraud HIV Infusion Scheme 2Health News:Federal Judge Sentences Defendants Who Perpetrated $10.9 Million Medicare Fraud HIV Infusion Scheme 3Health News:Federal Judge Sentences Defendants Who Perpetrated $10.9 Million Medicare Fraud HIV Infusion Scheme 4Health News:Duane Reade Holdings, Inc. Announces Closing of Offering of $300 Million of 11.75% Senior Secured Notes Due 2015 2Health News:Duane Reade Holdings, Inc. Announces Closing of Offering of $300 Million of 11.75% Senior Secured Notes Due 2015 3
Sterile squares of smooth foil for repair of the floor of the orbit and other plastic surgery. Available in large size....
Clear Base Stand Magnifiers are ideal for any visual task that requires high magnification....
Bausch & Lomb magnifiers incorporates precision optics and patented ergonomic designs for increased clarity and comfort during use....
Ultra Thin Sheet. Medpor Sheets are commonly used for orbital floor reconstruction and other craniofacial applications....
Medicine Products: